As the official conference of The Microbiome Coalition (TMBC), the Arrowhead Translational Microbiome Conference was the first microbiome conference in the field to focus exclusively on the hurdles and challenges to commercial success in the space. Once again, the conference will bring together the leading microbiome companies working to successfully commercialize microbiome-based diagnostics, therapeutics, adjunct therapies and direct-to-consumer services and products across a range of therapeutic areas, from gut to skin and beyond. Expanding on this core focus year on year, we continue to offer informative, hands-on workshops, panels sponsored and directed by industry to focus on your concerns and tightly curated content that goes beyond the usual infomercials to provide tangible and useful insights to how your peers are addressing their commercial approach to the space.
Entering its 5th year in 2019, the meeting will continue to focus and build on the challenges and hurdles that companies working in the microbiome space will have to recognize and navigate in order to successfully commercialize their products. However, we are responding to requests by attendees to include more basic research, ensure more work beyond the gut is incorporated into the agenda and expanding our prior parallel tracks on nutrition and consumer products.
Conference Topics Include:
- Animal Models
- Bioinformatics Challenges
- Investment Deals and Approaches
- Pharma Deals in the Microbiome Space
- Intellectual Property Management
- The Need for Standards
With a broad focus spanning multiple disease states (oncology, dermatology, inflammatory disorders, among others) attendees will have the opportunity to hear the leading companies discuss the work they have underway and how they are meeting these challenges head-on to apply recent discoveries to a variety of disease processes, restoration of health and improved outcomes.
For sponsorship/exhibitor enquiries, please get in touch
Entering its 5th year in 2019, the meeting will continue to focus and build on the challenges and hurdles that companies working in the microbiome space will have to recognize and navigate in order to successfully commercialize their products. However, we are responding to requests by attendees to include more basic research, ensure more work beyond the gut is incorporated into the agenda and expanding our prior parallel tracks on nutrition and consumer products.
Conference Topics Include:
- Animal Models
- Bioinformatics Challenges
- Investment Deals and Approaches
- Pharma Deals in the Microbiome Space
- Intellectual Property Management
- The Need for Standards
With a broad focus spanning multiple disease states (oncology, dermatology, inflammatory disorders, among others) attendees will have the opportunity to hear the leading companies discuss the work they have underway and how they are meeting these challenges head-on to apply recent discoveries to a variety of disease processes, restoration of health and improved outcomes.
For sponsorship/exhibitor enquiries, please get in touch
